Glioblastoma Clinical Trials in Houston, TX

Glioblastoma Clinical Trials in Houston, TX

View the best 10 glioblastoma medical studies in Houston, Texas. Access promising new therapies by applying to a Houston-based Glioblastoma clinical trial.

Trials in Houston, Texas

Here are the top 6 medical studies for glioblastoma in Houston, Texas

Image of The University of Texas M. D. Anderson Cancer Center in Houston, United States.

Ivonescimab

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
"This trial aims to determine the highest safe dose of ivonescimab for patients with recurrent glioblastoma in Phase 1. In Phase 2, researchers will test if this dose can
Image of Children's Hospital Los Angeles in Los Angeles, United States.

BGB-290 +1 More

PARP Inhibitor

Recruiting1 awardPhase 1
This trial studies the safety and best dose of BGB-290 and temozolomide in treating young people with a specific type of brain tumor. BGB-290 blocks enzymes needed for tumor growth, while temozolomide kills or stops cancer cells from growing. The goal is to find out if this combination works better for these patients.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Temozolomide +2 More

Alkylating agents

Recruiting1 awardPhase 2
This trial is studying how well two types of radiation therapy work compared to standard radiation therapy when given with temozolomide in patients with newly diagnosed glioblastoma.
Image of Children's Hospital of Alabama in Birmingham, United States.

Temozolomide +2 More

Alkylating Agent

Recruiting1 awardPhase 2
This trial is studying a combination of drugs as a potential treatment for newly diagnosed malignant glioma. The drugs being studied are veliparib, radiation therapy, and temozolomide.
Image of Centralia Oncology Clinic in Centralia, United States.

Lomustine +2 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Temozolomide

Alkylating agents

Recruiting0 awardsPhase 2 & 3
This trial is studying the combination of temozolomide and veliparib compared to temozolomide alone in treating patients with newly diagnosed glioblastoma multiforme.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' ā€” so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back ā€” in general, verified trials respond to patients within a few days.